Mar Cor signs distribution agreement with Rephile Biosciences

The agreement covers laboratory water used in research, hospitals and other high purity, low volume applications

Mar Cor Purification, a subsidiary of Cantel Medical and a specialist in purified water systems, is to distribute the laboratory water systems of RephiLe Biosciences to customers in North America.

These systems are used in research facilities, universities, hospitals and other critical high purity, low volume applications.

The broad line of systems are capable of producing various grades of high purity water used in lab, research, blood analysers and other grades of water.

“The RephiLe line of laboratory systems are designed to meet the increasing requirements of our customers by providing technically advanced, innovative systems coupled with a robust design,” said Christopher Fournier, VP Marketing, Mar Cor.

“Our direct sales force of over 50 professional sales people will have full access to the entire product line in order to address the specialised capacity requirements of the laboratory market.”

Peter Lucas, President, North America, RephiLe Biosciences said: “Mar Cor provides unparalleled support to its water purification customers from a sales and service perspective. With Mar Cor’s 30 service and regeneration centers across North America, coupled with experienced sales and service teams, our customers will have coverage for installation, service, and maintenance of RephiLe Biosciences water purification systems. This agreement continues to build upon our strategic and tactical expansion in North America to offer our customers outstanding products and support.”

Companies